BioInvent International AB
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About BioInvent International AB
BioInvent International AB is a clinical-stage biotech company. It discovers and develops novel and first-in-class immuno-modulatory antibodies for cancer therapy, with currently four drug candidates in five ongoing clinical programs in Phase 1/2 trials for the treatment of hematological cancer and solid tumors, respectively. The company's validated, proprietary F.I.R.S.T technology platform identifies both targets and the antibodies that bind to them, generating many new drug candidates to fuel the company's clinical development pipeline and providing licensing and partnering opportunities. The company's pipeline portfolio comprises BI-1206, an antagonistic blocking antibody for the treatment of non-Hodgkin’s lymphoma, and BI-1808 and BI-1910 (anti-TNFR2) for solid cancers.
/ 
Frequently asked questions
To buy BioInvent International AB stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for BioInvent International AB by name or ticker, choose the number of shares, and place your order.
The ticker symbol for BioInvent International AB is BINV:xome. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
BioInvent International AB has its primary listing on NASDAQ OMX Stockholm. You can trade BioInvent International AB with a Saxo account, alongside thousands of other stocks worldwide.
Yes, BioInvent International AB is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include BioInvent International AB as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like BioInvent International AB.